Lifts Price Target to $20 From $17
https://www.marketscreener.com/news/morgan-stanley-downgrades-10x-genomics-to-equalweight-from-overweight-lifts-price-target-to-20-fro-ce7d51d9db8afe22
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.